Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025European Journal of Pharmaceutical SciencesOpen Access

Prevalence and Risk Assessment of Drug Allergies in Hospitalized Patients: Potential for Allergy Delabeling

View Full Paper
Ask AI
Bookmark
Share

Authors

RNRóbert NacsaMMMária MatúzEPErika Papfalvi

Discussion

Loading...

Member takes

Overview

Cross-sectional study evaluates drug allergy prevalence and delabeling potential in hospitalized adults, suggesting implications for antimicrobial resistance.

Key Points

  • About 15.9% of hospitalized patients reported drug allergies, indicating a significant prevalence.
  • Among 384 allergy cases assessed, 252 (90.97%) were classified as low risk and eligible for delabeling.
  • A structured questionnaire was used to collect data on adverse drug reactions across multiple surgical wards.
  • This highlights the need for systematic allergy evaluations and delabeling as part of stewardship programs.

Cite This Study

Nacsa et al. (2025) studied this question.

synapsesocial.com/papers/68c1ce6754b1d3bfb60f57f2https://doi.org/10.1016/j.ejps.2025.107240
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Drug Allergy in Hospitalized Patients: Three Years of Consultation Experience in a Tertiary Care Setting2025
  2. 2Availability and Efficacy of Assessment Strategies for Delabelling of Antibiotic Allergies, and the Role of the Pharmacist.2023
  3. 3Characterizing β-lactam allergy prevalence among patients receiving infectious disease specialty care within a large US healthcare system in Washington2026
  4. 4Direct single dose mass delabelling of antibiotic allergy in pediatrics2026 · 1 citations
  5. 5Antibiotic Allergy Labeling in Primary Care: Challenges, Consequences, and a Path Forward2026